Pediatric brain tumors: current treatment strategies and future therapeutic approaches.
Pediatric CNS tumors are the most common solid tumors of childhood and the second most common cancer after hematological malignancies accounting for approximate 20 to 25% of all primary pediatric tumors. With over 3,000 new cases per year in the United States, childhood CNS tumors are the leading cause of death related to cancer in this population. The prognosis for these patients has improved over the last few decades, but current therapies continue to carry a high risk of significant side effects, especially for the very young. Currently a combination of surgery, radiation, and chemotherapy is often used in children greater than 3 years of age. This article will outline current and future therapeutic strategies for the most common pediatric CNS tumors, including primitive neuroectodermal tumors such as medulloblastoma, as well as astrocytomas and ependymomas.
Mueller
Sabine
S
Department of Neurology, Division of Child Neurology, University of San Francisco, San Francisco, California, USA. muellers@neuropeds.ucsf.edu
Chang
Susan
S
D000818:Animals; D001254:Astrocytoma / Q000628:therapy; D001932:Brain Neoplasms / Q000628:therapy*; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000379:methods; D004806:Ependymoma / Q000503:physiopathology / Q000628:therapy; D005910:Glioma / Q000628:therapy; D006801:Humans; D008527:Medulloblastoma / Q000628:therapy; D009367:Neoplasm Staging; D017599:Neuroectodermal Tumors / Q000628:therapy*; D019635:Neurosurgical Procedures / Q000379:methods; D011878:Radiotherapy / Q000379:methods